Issue 35, 2021
From the journal:

Chemical Science

Correction: An engineered biosynthetic–synthetic platform for production of halogenated indolmycin antibiotics

Elesha R. Hoffarth,a   Sunnie Kong,a   Hai-Yan Hea  and  Katherine S. Ryan*a  

* Corresponding authors

a Department of Chemistry, The University of British Columbia, Vancouver, Canada
E-mail: ksryan@chem.ubc.ca

Abstract

Correction for ‘An engineered biosynthetic–synthetic platform for production of halogenated indolmycin antibiotics’ by Elesha R. Hoffarth et al., Chem. Sci., 2021, 12, 8817–8821, DOI: 10.1039/D0SC05843B.

About
Cited by
Related
Download options Please wait...

Associated articles

Article information

DOI
https://doi.org/10.1039/D1SC90180J
Article type
Correction
Submitted
16 Aug 2021
Accepted
16 Aug 2021
First published
03 Sep 2021
This article is Open Access

All publication charges for this article have been paid for by the Royal Society of Chemistry
Creative Commons BY license

Chem. Sci., 2021,12, 11921-11921

Permissions

Request permissions

Correction: An engineered biosynthetic–synthetic platform for production of halogenated indolmycin antibiotics

E. R. Hoffarth, S. Kong, H. He and K. S. Ryan, Chem. Sci., 2021, 12, 11921 DOI: 10.1039/D1SC90180J

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements